Emile Sharifi, M.D.

Emile Sharifi, M.D. first joined SoCal Eye in 2016, working as a comprehensive, Uveitis, and Cornea specialist. He earned his Bachelor of Arts at the University of California Los Angeles (UCLA) in 2001, as a member of the Phi Beta Kappa Honors Society and graduating Summa Cum Laude. After obtaining his medical degree in 2007 from the University of California San Francisco (UCSF), Dr. Sharifi became the only Uveitis specialist in private practice in Southern California to have completed a Uveitis and Ocular Immunology fellowship.

After successfully completing a three-year residency training in comprehensive Ophthalmology in 2013, Dr. Sharifi continued to an International Ophthalmology Fellowship working as a Staff Ophthalmologist at ORBIS International. The next year, he went on to complete his Uveitis Fellowship & Ocular Immunology at New York Eye & Ear Infirmary, under the mentorship of Drs. Michael Samson, Douglas Jabs, and Sanjay Kedhar in the diagnosis, surgical and medical management of Uveitis and other ocular inflammatory diseases. Finally, before he joined our team at SoCal Eye, Dr. Sharifi completed his Cornea, External Eye, and Refractive Surgery Fellowship at the University of Southern California, where he was trained in numerous refractive procedures such as LASIK, PRK, keratoplasty, open globe repairs, and femtosecond cataract laser cases.

As of April 2017, Dr. Sharifi has served as a director of clinical trials here at SoCal Eye where he has worked on multiple studies including OTX-TP Glaucoma, Sunrise study of experimental agent SUN-131 in chalazion, Clinical Endpoint Study of Nepafenac 0.3% Ophthalmic Suspension, and DELTA-1 study of topical PPAR inhibitor for treatment of dry eye disease. Along with authoring several publications, Dr. Sharifi takes pride in traveling around to different departments in New York and Washington, providing multiple educational and conference presentations to doctors. He is also the co-founder of the largest health related international organization in California with several hundred members from over 100 countries.

EDUCATION

University of California
Los Angeles, CA
Major: European Studies
Degree: Bachelor of Arts – European Studies
Robert C. Byrd merit scholarship; 1996-2000
1996-2001

University of California
San Francisco, CA
Doctor of Medicine
2003-2007

California Pacific Medical Center
San Francisco, CA
Preliminary Medicine Internship
2008-2009

University of Washington
Seattle, WA
Ophthalmology Residency
2010-2013

ORBIS International
International Ophthalmology Fellowship
Staff Ophthalmologist – Mongolia, Indonesia, and China
Clinical Ophthalmologist – Cameroon, Panama, and India
2013-2014

New York Eye & Ear Infirmary
New York, New York
Uveitis Fellowship & Ocular Immunology
2014-2015

University of Southern California
Los Angeles, CA
Cornea, External Eye, and Refractive Surgery Fellowship
2015-2016

INTERESTS / SKILLS

Dr. Sharifi speaks and reads Arabic fluently as well as Medical Spanish. He enjoys SCUBA diving, skiing, hiking, and cooking international cuisine.

PUBLICATIONS

2017      Characteristics, Challenges and Long Term Visual Outcome of Corneal Surgery on the Flying Eye Hospital: a 5-year review. Farooqui  J, Sharifi E, Gomaa A. Canadian Journal of Ophthalmology. April 2017, Volume 52, Issue 2, Pages 161-165

2015   Chikungunya-associated Uveitis and exudative retinal detachment: a case reportScripsema N, Sharifi E, Samson CM, Kedhar S, Rosen RB. Retina Brief Case Reports. 2015 Fall; 9(4):352-6

2009      Coexisting Tattoo pigment and metastatic melanoma in the same sentinel lymph node Jaigirdar AA, Yeh MW, Sharifi E, Browne LW, Leong SP. J Cutan Med Surg. 2009 Nov-Dec;13(6):321-5.

2009      Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery Sharifi E, Porco TC, Naseri A. Ophthalmology. 2009 Oct;116(10):1887-96.e1. Epub 2009 Jun 28

PRESENTATIONS

An update: Combined systemic and intravitreal antiviral treatment in acute retinal necrosis. Masako Chen, Emile Sharifi, Diaz Vicente, John Mauro, C M. Samson, Sanjay Kedhar

Duration of Immunomodulator Therapy on Five-Year Uveitis Remission Rates. Yijie Lin, Emile Sharifi, David Mostafavi, Danielle Rome, Michael Tang, Tiffany Truong, Vicente Diaz, Sanjay Kedhar, John Mauro, C, M. Samson.

Educational Presentations
New York Eye and Ear Infirmary. Retina In-Service Lecture Series.
“A year of Uveitis Fellowship in one hour”

New York Eye and Ear Infirmary. Retina In-Service Lecture Series.
“Uveitis Grand Rounds.”

New York Eye and Ear Infirmary. Retina In-Service Lecture Series.
“White Dot Syndromes.”